GRAIL

Tune in to the LinkedIn Live discussion “Innovating with Early Cancer Detection in Leading Health Systems: Exploring the role and implementation of multi-cancer early detection (MCED) testing,” where the panelists from Mercy and Providence will discuss how MCED testing works in their health care systems. Click here to RSVP: https://bit.ly/3ybzayH   #MCED #CancerScreening

On May 21st, a panel of leading experts will convene for a LinkedIn Live event to discuss the growing adoption of multi-cancer early detection (MCED) testing in health systems. Join us to hear key learnings and their future vision. Click here for more event details: https://bit.ly/3UBfLyz

How do you navigate cancer risk factors, like genetics and age – and how can adding multi-cancer early detection testing help? Hear more about how the women of one family are answering these questions on our podcast #TheCancerSignal: https://bit.ly/4brhnSt #WomensHealthMonth

We are looking forward to presenting an upcoming LinkedIn Live event where esteemed panelists will discuss multi-cancer early detection (MCED) testing in their own health care systems, their vision for the future of MCED testing, and more. Click for more details: https://bit.ly/3UBfLyz #MCED #CancerScreening

This week, the Cancer Moonshot shared updates from those in the private sector working to advance cancer screening and prevention. Among the updates was GRAIL's real-world evidence program investigating the use of multi-cancer early detection in addition to recommended cancer screenings. See the full Cancer Moonshot update below and learn more about our research collaboration with the U.S. Department of Veterans Affairs and the Veterans Health Administration: https://bit.ly/44yGyQG

Our data at #ISPOR2024 investigated the larger emotional and economic impacts of #cancer screening. Here’s what we found: ✅ Negative multi-cancer early detection test results may have positive emotional impacts and improve other health behaviors, like adhering to future recommended cancer screening. 📈 Cancer screenings improve life expectancy and provide good economic value in many scenarios, particularly among higher risk groups. 💵 Existing assessments may underestimate the full value and impacts on society of cancer screenings by only considering certain costs or examining too short a time period. 🏥 Post-metastasis cancer diagnoses drive up healthcare costs and have lower success treatment rates, indicating that spending on cancer care among certain groups may be substantially reduced if cancers could be diagnosed earlier. See the full posters: https://bit.ly/3ufa1Bd

Diagnosing ovarian cancer early can improve the five-year survival rate for patients. Learn more from World Ovarian Cancer Coalition: https://bit.ly/2R5xMs1 #WorldOvarianCancerDay

🎙️ Don’t miss the latest episode of The Cancer SIGNAL: https://lnkd.in/e5yumdj8 Jonathon Rendina, PhD, MPH and Dwight Venson from Whitman-Walker discuss the disparities faced by LGBTQ+ people when seeking cancer screening. The INCLUDE study, a collaboration between Whitman-Walker, Cancer Support Community and GRAIL, aims to discover the impact of offering multi-cancer early detection testing to people at a federally qualified health center. Hear more about Whitman-Walker’s work and the INCLUDE study in the full episode. Apple Podcasts: https://apple.co/3W0dso3 Spotify: https://spoti.fi/3T8pay9 Amazon Music: https://amzn.to/3PbZAom

In 2024, more than 2 million new cancer cases are expected to be diagnosed in the US, according to the American Cancer Society. Multi-cancer early detection testing can help screen for many of the deadliest cancers that don’t have recommended screenings today. Finding particularly deadly cancers early may offer a chance to improve outcomes. Learn more about MCED: https://lnkd.in/gZvZZ6gS

Making #cancer screening more equitable could have a significant impact on outcomes for people in minority groups. In honor of #NationalMinorityHealthMonth, we’re looking back at episodes of #TheCancerSignal podcast where we explored the challenges of health disparities: 🎙️ Episode 6 highlights the importance of colorectal cancer screening in the Black community: https://lnkd.in/eQPKCq3c 🎙️ Dr. Gary Puckrein of the National Minority Quality Forum joins episode 8 to discuss how disparities in care lead to inequitable cancer outcomes: https://lnkd.in/eBmjAwh3 🎙️ Melissa Buffalo of the American Indian Cancer Foundation takes a closer look at the cancer burden faced by Native Americans and efforts to reduce disparities in episode 12: https://lnkd.in/euCRAj4u 🎙️ Episode 17 addresses the lower prevalence of genetic testing among people of color in the U.S., creating barriers to proactive screening: https://lnkd.in/ev-sVtEZ 🎙️ Episode 19 showcases how inequities can begin at the clinical trial level, and how newer clinical trials are working to counteract these biases: https://lnkd.in/eqvkrtjb